Key Decisions in HIV Care: Tenofovir Alafenamide in Pregnancy
Listen as Milena Murray, PharmD, MSc, BCIDP, AAHIVP, shares key data and recommendations to support the use of TAF in pregnancy.
Decera Clinical Education Infectious Disease Podcast · Milena Murray PharmD MSc BCIDP AAHIVP
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores the data to support the use of tenofovir alafenamide in pregnancy.
Listen as she gives her perspectives on:
- DHHS guideline recommendations for the use of TAF in pregnancy
- Pharmacokinetic data to support adequate TAF concentrations throughout pregnancy
- Available antiretroviral pregnancy registry information on the use of TAF in pregnancy
- Data from the IMPAACT 2010 study to support the use of a TAF-containing regimen in pregnancy
Presenter:
Milena Murray, PharmD, MSc, BCIDP, AAHIVP
Associate Professor
Pharmacy Practice
Midwestern University College of Pharmacy
Downers Grove Campus
HIV/ID Clinical Pharmacist
Northwestern Memorial Hospital
Chicago, Illinois
Follow along with the slides at:
https://bit.ly/3ofTHLr
Link to full program:
https://bit.ly/2TXTYWx
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.